BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26742785)

  • 1. Famous.
    Kim MJ; Bhatti MT; Costello F
    Surv Ophthalmol; 2016; 61(4):512-9. PubMed ID: 26742785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis.
    Fruschelli M; Capozzoli M; Gelmi MC; Masi G; Annunziata P
    Int Ophthalmol; 2019 Apr; 39(4):777-781. PubMed ID: 29500696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
    Ueda N; Saida K
    BMC Ophthalmol; 2015 Oct; 15():135. PubMed ID: 26481728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
    Thoo S; Cugati S; Lee A; Chen C
    Mult Scler; 2015 Feb; 21(2):249-51. PubMed ID: 24696055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
    Schröder K; Finis D; Harmel J; Ringelstein M; Hartung HP; Geerling G; Aktas O; Guthoff R
    Mult Scler Relat Disord; 2015 Sep; 4(5):406-408. PubMed ID: 26346788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?
    Pul R; Osmanovic A; Schmalstieg H; Pielen A; Pars K; Schwenkenbecher P; Sühs KW; Yildiz Ö; Frank B; Stangel M; Skripuletz T
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular oedema and changes in macular thickness in multiple sclerosis patients treated with fingolimod.
    Nørgaard TL; Andersen CU; Hilt C; Andersen CU
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126(6):492-497. PubMed ID: 31880065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does fingolimod in multiple sclerosis patients cause macular edema?
    Turaka K; Bryan JS
    J Neurol; 2012 Feb; 259(2):386-8. PubMed ID: 22231867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and recurrent macular oedema in a patient treated with fingolimod.
    Cifuentes-Canorea P; Nieves-Moreno M; Sáenz-Francés F; Santos-Bueso E
    Neurologia (Engl Ed); 2019 Apr; 34(3):206-207. PubMed ID: 27776961
    [No Abstract]   [Full Text] [Related]  

  • 10. Fingolimod-associated macular oedema.
    Jasani KM; Sharaf N; Rog D; Aslam T
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28619738
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystoid macular edema associated with fingolimod use for multiple sclerosis.
    Afshar AR; Fernandes JK; Patel RD; Ksiazek SM; Sheth VS; Reder AT; Hariprasad SM
    JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220
    [No Abstract]   [Full Text] [Related]  

  • 12. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
    Zarbin MA; Jampol LM; Jager RD; Reder AT; Francis G; Collins W; Tang D; Zhang X
    Ophthalmology; 2013 Jul; 120(7):1432-9. PubMed ID: 23531349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod therapy and macular hemorrhage.
    Bhatti MT; Freedman SM; Mahmoud TH
    J Neuroophthalmol; 2013 Dec; 33(4):370-2. PubMed ID: 23845997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fingolimod treatment in multiple sclerosis leads to increased macular volume.
    Nolan R; Gelfand JM; Green AJ
    Neurology; 2013 Jan; 80(2):139-44. PubMed ID: 23223539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cystoid macular oedema after fingolimod treatment in multiple sclerosis].
    Asensio-Sánchez VM; Trujillo-Guzmán L; Ramoa-Osorio R
    Arch Soc Esp Oftalmol; 2014 Mar; 89(3):104-6. PubMed ID: 24269406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early onset of fingolimod-associated macular edema].
    Schelenz D; Kleiter I; Schöllhammer J; Rehrmann J; Elling M; Dick HB; Kakkassery V
    Ophthalmologe; 2018 May; 115(5):424-428. PubMed ID: 28653209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world incidence of fingolimod-associated macular oedema.
    Goh LY; Kirthi V; Silber E; Harvey JP; Jackson TL
    Mult Scler Relat Disord; 2020 Jul; 42():102125. PubMed ID: 32403070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fingolimod-associated macular edema: A case report of late onset.
    Karakosta C; Kourentis C
    Eur J Ophthalmol; 2022 Jul; 32(4):NP56-NP60. PubMed ID: 33645300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient.
    Saab G; Almony A; Blinder KJ; Schuessler R; Brennan DC
    Arch Ophthalmol; 2008 Jan; 126(1):140-1. PubMed ID: 18195237
    [No Abstract]   [Full Text] [Related]  

  • 20. Higher macular volume in patients with MS receiving fingolimod: positive outcome or side effect?
    Dinkin M; Paul F
    Neurology; 2013 Jan; 80(2):128-9. PubMed ID: 23223537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.